BMRN - Company ID 0001048477
The table below shows BIOMARIN PHARMACEUTICAL INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $736.01M | $874.00M | $2.22B | $1.25B | $1.21B | $1.05B |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $1.08B | $1.06B | $903.91M | $790.27M | $855.86M | $739.18M |
| Inventory | $1.80B | $1.78B | $1.27B | $1.38B | $1.34B | $1.27B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $3.92B |
| $3.97B |
| $4.61B |
| $3.85B |
| $3.81B |
| $3.47B |
| Property, plant & equipment | $980.08M | $989.99M | $958.07M | $1.04B | $1.03B | $1.03B |
| Goodwill | $666.37M | $655.75M | $196.20M | $196.20M | $196.20M | $196.20M |
| Total assets | $11.57B | $11.72B | $8.59B | $7.61B | $7.46B | $7.15B |
| Accounts payable | $130.72M | - | - | - | - | - |
| Total current liabilities | $1.60B | $1.66B | $793.15M | $798.44M | $684.25M | $628.21M |
| Long-term debt | $3.51B | $3.53B | $1.43B | - | - | - |
| Total liabilities | $5.31B | $5.40B | $2.38B | $1.56B | $1.43B | $1.35B |
| Retained earnings | $181.66M | $304.50M | $259.73M | $200.78M | $231.52M | -$9.01M |
| Total equity | $6.26B | $6.32B | $6.21B | $6.06B | $6.03B | $5.79B |